You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

neo-adjuvant treatment in early stage NSCLC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

INnovative and Micro-INvasive TEchniques for Early

Recruiting
  • Breast Cancer
  • Liquid biopsy and imaging
  • Aviano, Pordenone, Italy
    Centro di Riferimento Oncologico
Apr 26, 2023

Melanoma Stage III, Melanoma Stage IV Trial in Amsterdam (T-VEC)

Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • Amsterdam, NH, Netherlands
    Antoni van Leeuwenhoek ziekenhuis
Feb 11, 2022

Melanoma Stage III, In-Transit Metastasis of Cutaneous Melanoma Trial in Leiden (Encorafenib + Binimetinib)

Recruiting
  • Melanoma Stage III
  • In-Transit Metastasis of Cutaneous Melanoma
  • Encorafenib + Binimetinib
  • Leiden, Zuid-Holland, Netherlands
    Leiden University Medical Center
Mar 2, 2023

Colorectal Cancer Trial in China (Tislelizumab)

Recruiting
  • Colorectal Cancer
  • Bengbu, Anhui, China
  • +7 more
Sep 13, 2022

Lung Cancer, Non-small Cell Trial in Jerusalem (Tagrisso)

Recruiting
  • Lung Cancer, Non-small Cell
  • Jerusalem, Israel
    Shaare Zedek Medical Center
Nov 10, 2021

NSCLC Trial (Atezolizumab, Tiragolumab)

Not yet recruiting
  • NSCLC
  • (no location specified)
Apr 5, 2023

NSCLC Trial (Dupilumab, Cemiplimab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Dupilumab
  • Cemiplimab
  • (no location specified)
Oct 12, 2023

Ovarian Cancer Stage IV, Peritoneal Cancer, Fallopian Tube Cancer Trial in Amsterdam (Carboplatin, Paclitaxel, Pembrolizumab)

Recruiting
  • Ovarian Cancer Stage IV
  • +2 more
  • Amsterdam, Netherlands
    Antoni van Leeuwenhoek
Mar 21, 2022

NSCLC Stage II, NSCLC, Stage IIIA Trial in Goyang-si (Erlotinib)

Active, not recruiting
  • NSCLC Stage II
  • NSCLC, Stage IIIA
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
Apr 4, 2022

NSCLC Trial in Shanghai (SH-1028 tablets, Placebo SH-1028 tablets)

Recruiting
  • Non-small Cell Lung Cancer
  • SH-1028 tablets
  • Placebo SH-1028 tablets
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Oct 6, 2023

Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2

Recruiting
  • HER2-positive Breast Cancer
  • Early-stage Breast Cancer
  • pyrotinib combined with Capecitabine
  • treatment of physician's choice
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 6, 2023

NSCLC Trial (Durvalumab)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
Jun 22, 2023

NSCLC, Stage I Trial in Tianjin (Osimertinib)

Recruiting
  • NSCLC, Stage I
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Jan 6, 2023

Early Breast Cancer Trial (Ribociclib, Letrozole, Ansastrozole)

Not yet recruiting
  • Early Breast Cancer
  • (no location specified)
Apr 12, 2023

NSCLC, NSCLC Stage I, NSCLC Stage II Trial in Stanford (AVENIO ctDNA Surveillance Kit, Durvalumab)

Recruiting
  • Non-small Cell Lung Cancer
  • +3 more
  • Stanford, California
    Stanford University
Mar 25, 2022

Stage IIIB(N2) NSCLC, Stage IIA NSCLC, Stage IIB NSCLC Trial in Beijing (Pembrolizumab 200 mg IV infusion)

Not yet recruiting
  • Stage IIIB(N2) Non-small Cell Lung Cancer
  • +3 more
  • Pembrolizumab 200 mg IV infusion
  • Beijing, Beijing, China
    Peking University
May 30, 2023

Omitting Clinical Target Volume in Radical Treatment of

Not yet recruiting
  • Immunotherapy
  • +3 more
  • IMRT+adjuvant immunotherapy
  • (no location specified)
Jun 9, 2023

NSCLC, Stage II-IIIA, Immunotherapy Trial in Shanghai (Serplulimab and Chemotherapy)

Recruiting
  • Non-small Cell Lung Cancer
  • +3 more
  • Serplulimab and Chemotherapy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 27, 2023

Early-stage Breast Cancer Trial in Brno (APBI, WBI)

Completed
  • Early-stage Breast Cancer
  • APBI
  • WBI
  • Brno, Czech Republic, Czechia
    Masaryk Memorial Cancer Institute
Aug 17, 2023

Endometrial Cancer Trial (Vaginal brachytherapy, Adjuvant radiotherapy (EBRT +/- brachytherapy), Observation)

Not yet recruiting
  • Endometrial Cancer
  • Vaginal brachytherapy
  • +2 more
  • (no location specified)
Nov 29, 2022

NSCLC Trial (Icotinib)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • (no location specified)
Aug 23, 2022

Early-stage HER2-positive Breast Cancer, Treated With Neratinib

Recruiting
  • Breast Cancer
  • +2 more
    • Bouge, Belgium
      Clinique Saint-Luc Bouge
    Oct 25, 2022

    Malignant Melanoma Stage III Trial in Worldwide (Ipilimumab, Nivolumab, Surgery)

    Active, not recruiting
    • Malignant Melanoma Stage III
    • Sydney, New South Wales, Australia
    • +3 more
    Apr 14, 2022

    Triple-negative Breast Cancer Trial (Pembrolizumab 25 mg/ml, Paclitaxel injection)

    Not yet recruiting
    • Triple-negative Breast Cancer
    • Pembrolizumab 25 mg/ml
    • Paclitaxel injection
    • (no location specified)
    Oct 11, 2023

    NSCLC, Stage I Trial (Tislelizumab monotherapy)

    Not yet recruiting
    • NSCLC, Stage I
    • Tislelizumab monotherapy
    • (no location specified)
    Mar 9, 2022